164 related articles for article (PubMed ID: 33247498)
41. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
42. Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.
Shi R; Radulovich N; Ng C; Liu N; Notsuda H; Cabanero M; Martins-Filho SN; Raghavan V; Li Q; Mer AS; Rosen JC; Li M; Wang YH; Tamblyn L; Pham NA; Haibe-Kains B; Liu G; Moghal N; Tsao MS
Clin Cancer Res; 2020 Mar; 26(5):1162-1174. PubMed ID: 31694835
[TBL] [Abstract][Full Text] [Related]
43. Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors.
Maru Y; Tanaka N; Itami M; Hippo Y
Gynecol Oncol; 2019 Jul; 154(1):189-198. PubMed ID: 31101504
[TBL] [Abstract][Full Text] [Related]
44. New targets for therapy in prostate cancer: modulation of stromal-epithelial interactions.
Chung LW; Hsieh CL; Law A; Sung SY; Gardner TA; Egawa M; Matsubara S; Zhau HE
Urology; 2003 Nov; 62(5 Suppl 1):44-54. PubMed ID: 14607217
[TBL] [Abstract][Full Text] [Related]
45. Prostate organoids: emerging experimental tools for translational research.
Beshiri M; Agarwal S; Yin JJ; Kelly K
J Clin Invest; 2023 May; 133(10):. PubMed ID: 37183816
[TBL] [Abstract][Full Text] [Related]
46. Microarray analysis of xenograft-derived cancer cell lines representing multiple experimental models of human prostate cancer.
Glinsky GV; Krones-Herzig A; Glinskii AB; Gebauer G
Mol Carcinog; 2003 Aug; 37(4):209-21. PubMed ID: 12891630
[TBL] [Abstract][Full Text] [Related]
47. Organoid culture systems for prostate epithelial and cancer tissue.
Drost J; Karthaus WR; Gao D; Driehuis E; Sawyers CL; Chen Y; Clevers H
Nat Protoc; 2016 Feb; 11(2):347-58. PubMed ID: 26797458
[TBL] [Abstract][Full Text] [Related]
48. [From tumor tissue via primary cultures to xenograft models: a functional approach in prostate cancer research].
Saar M; Kamradt J; Jung V; Stöckle M; Unteregger G
Urologe A; 2011 Aug; 50(8):961-7. PubMed ID: 21728008
[TBL] [Abstract][Full Text] [Related]
49. 3D Hanging Drop Culture to Establish Prostate Cancer Organoids.
Eder T; Eder IE
Methods Mol Biol; 2017; 1612():167-175. PubMed ID: 28634942
[TBL] [Abstract][Full Text] [Related]
50. Modeling human prostate cancer progression in vitro.
Liu TT; Ewald JA; Ricke EA; Bell R; Collins C; Ricke WA
Carcinogenesis; 2019 Jul; 40(7):893-902. PubMed ID: 30590461
[TBL] [Abstract][Full Text] [Related]
51. Patient-derived xenografts and organoids model therapy response in prostate cancer.
Karkampouna S; La Manna F; Benjak A; Kiener M; De Menna M; Zoni E; Grosjean J; Klima I; Garofoli A; Bolis M; Vallerga A; Theurillat JP; De Filippo MR; Genitsch V; Keller D; Booij TH; Stirnimann CU; Eng K; Sboner A; Ng CKY; Piscuoglio S; Gray PC; Spahn M; Rubin MA; Thalmann GN; Kruithof-de Julio M
Nat Commun; 2021 Feb; 12(1):1117. PubMed ID: 33602919
[TBL] [Abstract][Full Text] [Related]
52. Initiation, Expansion, and Cryopreservation of Human Primary Tissue-Derived Normal and Diseased Organoids in Embedded Three-Dimensional Culture.
Clinton J; McWilliams-Koeppen P
Curr Protoc Cell Biol; 2019 Mar; 82(1):e66. PubMed ID: 30265443
[TBL] [Abstract][Full Text] [Related]
53. Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal cultures.
Brennen WN; Kisteman LN; Isaacs JT
Prostate; 2016 May; 76(6):552-64. PubMed ID: 26732992
[TBL] [Abstract][Full Text] [Related]
54. Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples.
Festuccia C; Angelucci A; Gravina GL; Muzi P; Miano R; Vicentini C; Bologna M
Int J Oncol; 2005 May; 26(5):1353-62. PubMed ID: 15809728
[TBL] [Abstract][Full Text] [Related]
55. CWR22 xenograft as an ex vivo human tumor model for prostate cancer gene therapy.
Cheng L; Sun J; Pretlow TG; Culp J; Yang NS
J Natl Cancer Inst; 1996 May; 88(9):607-11. PubMed ID: 8609662
[TBL] [Abstract][Full Text] [Related]
56. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
[TBL] [Abstract][Full Text] [Related]
57. Application of Cancer Organoid Model for Drug Screening and Personalized Therapy.
Kondo J; Inoue M
Cells; 2019 May; 8(5):. PubMed ID: 31108870
[TBL] [Abstract][Full Text] [Related]
58. [Exploration of organoid in breast cancer related research].
Zheng X; Li J; Sheng J; Zhuo Q; Du Q; Xu Y
Sheng Wu Gong Cheng Xue Bao; 2021 Feb; 37(2):395-403. PubMed ID: 33645143
[TBL] [Abstract][Full Text] [Related]
59. Organoid and Spheroid Tumor Models: Techniques and Applications.
Gunti S; Hoke ATK; Vu KP; London NR
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669619
[TBL] [Abstract][Full Text] [Related]
60. Current Status of Patient-Derived Ovarian Cancer Models.
Maru Y; Hippo Y
Cells; 2019 May; 8(5):. PubMed ID: 31130643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
